Fine specificity of the murine antibody response to HIV-1 gp160 determined by synthetic peptides which define selected epitopes
- 31 August 1992
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 29 (7-8), 989-998
- https://doi.org/10.1016/0161-5890(92)90138-n
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Fresh pathways to followNature, 1990
- Peptide Component Vaccine Engineering: Targeting the AIDS VirusInternational Reviews of Immunology, 1990
- T-cell strategies in AIDS vaccinesAIDS, 1989
- Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic responseCellular Immunology, 1988
- Different H–2 subregions influence immunization against retrovirus and immunosuppressionNature, 1987
- Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptorCell, 1987
- Antiserum to a Synthetic Peptide Recognizes the HTLV-III Envelope GlycoproteinScience, 1986
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983